We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current VIGL market cap is 139.81M. The company's latest EPS is USD -2.1987 and P/E is -1.68.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -20.78M | -21.91M | -22.32M | -23.86M | -21.42M |
| Net Income | -19.8M | -20.17M | -20.5M | -22.17M | -19.94M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -27.21M | -42.41M | -68.88M | -88.87M |
| Net Income | -28.55M | -43.28M | -68.31M | -82.64M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 192.36M | 175.41M | 159.16M | 140.86M | 125.08M |
| Total Liabilities | 21.02M | 21.57M | 23.32M | 24.61M | 21.3M |
| Total Equity | 171.34M | 153.84M | 135.84M | 116.25M | 103.78M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 25.3M | 102.44M | 200.39M | 140.86M |
| Total Liabilities | 6.55M | 9.95M | 11.31M | 24.61M |
| Total Equity | -28.28M | -69.44M | 189.08M | 116.25M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -22.19M | -37.54M | -54.85M | -70.36M | -21.88M |
| Investing | -69M | -91.11M | -75.79M | -65.14M | 16.47M |
| Financing | 203k | 782k | 835k | 888k | 5.18M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.18M | -39.35M | -65.15M | -70.36M |
| Investing | -500k | -204k | -921k | -65.14M |
| Financing | 29.83M | 107.75M | 161.26M | 888k |
| Market Cap | 139.81M |
| Price to Earnings Ratio | -1.68 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.67 |
| Price to Book Ratio | 1.19 |
| Dividend Yield | - |
| Shares Outstanding | 37.58M |
| Average Volume (1 week) | 164.72k |
| Average Volume (1 Month) | 333.17k |
| 52 Week Change | -61.25% |
| 52 Week High | 10.2201 |
| 52 Week Low | 2.47 |
| Spread (Intraday) | 0.35 (8.86%) |
| Company Name | Vigil Neuroscience Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.vigilneuro.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
